How a joined-up development strategy pays off for early-stage biotechs

Parexel Biotech’s Nate Akers and Vicky Hsu discuss how important it is for biotechs to align clinical execution with a clearly defined regulatory strategy to increase the chance of success for a new drug program.


Open PDF

Return to Insights Center

Related Insights

Article

Expedited Pathways Comparisons - US EU CHN

Oct 19, 2021

Blog

Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development

Mar 12, 2024

Article

Part 1 - Preparing for a Risk-Based Future: What ICH Revisions Mean for Clinical Trial Design and Conduct

Sep 14, 2021

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Blog

Overcoming risks in Phase 3 trials to accelerate time to market

Jan 22, 2025

Blog

Proof of product safety and efficacy: how to move ahead successfully in Phase 2 clinical development

Jan 22, 2025

Article

8 things you need to know about eCTDs in China

Jul 1, 2022

Video

Overcoming asset transfer challenges during a merger and acquisition (M&A)

Oct 20, 2021

Webinar

Accelerated Early Phase Decision-Making – Insider Insights to Speed Development

Jan 7, 2025

Playbook

Insights from the 2022 R&D Innovation Survey

Feb 17, 2023

Video

Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Blog

Focusing on value drivers to reduce risk in early-stage drug development

Jan 6, 2025

Related Insights

Article

Expedited Pathways Comparisons - US EU CHN

Oct 19, 2021

Blog

Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development

Mar 12, 2024

Article

Part 1 - Preparing for a Risk-Based Future: What ICH Revisions Mean for Clinical Trial Design and Conduct

Sep 14, 2021

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Blog

Overcoming risks in Phase 3 trials to accelerate time to market

Jan 22, 2025

Blog

Proof of product safety and efficacy: how to move ahead successfully in Phase 2 clinical development

Jan 22, 2025

Show more